Contact
searchSearch
HMP Global

Ulcerative Colitis Topic Center

Featured Content

News
Ozanimod Effective in Biologic-Exposed UC Patients
03/17/2025
Jessica Garlewicz
Some patients in the open-label extension of TRUE NORTH required more time to respond, but efficacy appears durable up to 3 years.
Some patients in the open-label extension of TRUE NORTH required more time to respond, but efficacy appears durable up to 3 years.
Some patients in the open-label...
03/17/2025
Advances in Inflammatory Bowel Disease Network
News
Upadacitinib Demonstrates Improved Outcomes Over Tofacitinib in Ulcerative Colitis
03/17/2025
Jessica Garlewicz
One year after initiation, patients receiving upadacitinib were at significantly lower risk of colectomy than those treated with tofacitinib.
One year after initiation, patients receiving upadacitinib were at significantly lower risk of colectomy than those treated with tofacitinib.
One year after initiation,...
03/17/2025
Advances in Inflammatory Bowel Disease Network
Research Highlights
Colectomy Associated With Risk of Kidney Failure
02/03/2025
Jessica Garlewicz
Patients undergoing colectomy may benefit from enhanced kidney function monitoring, surveillance, and timely referral to nephrology care.
Patients undergoing colectomy may benefit from enhanced kidney function monitoring, surveillance, and timely referral to nephrology care.
Patients undergoing colectomy...
02/03/2025
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Frank Scott, MD, on the AGA Guidelines for Ulcerative Colitis Management
12/30/2024
In this IBD Drive Time podcast, Dr Frank Scott from the University of Colorado and host Dr Raymond Cross discuss updates in the AGA guidelines for ulcerative colitis.
In this IBD Drive Time podcast, Dr Frank Scott from the University of Colorado and host Dr Raymond Cross discuss updates in the AGA guidelines for ulcerative colitis.
In this IBD Drive Time podcast,...
12/30/2024
Advances in Inflammatory Bowel Disease Network
Maia Kayal
Video
Maia Kayal MD, on Strategies for Managing Patients When Mesalamine Fails
12/27/2024
Dr Kayal reviews the options available when patients with ulcerative colitis do not respond or lose response to mesalamine therapy, and the considerations of patient factors, patient preferences, and safety that should be taken into account.
Dr Kayal reviews the options available when patients with ulcerative colitis do not respond or lose response to mesalamine therapy, and the considerations of patient factors, patient preferences, and safety that should be taken into account.
Dr Kayal reviews the options...
12/27/2024
Advances in Inflammatory Bowel Disease Network
Poll
Poll: Treating Acute Severe Ulcerative Colitis
12/17/2024
Rebecca Mashaw
With many recently approved therapies for ulcerative colitis available today, which do you turn to first for patients hospitalized for acute severe ulcerative colitis? Let us know in our poll!
With many recently approved therapies for ulcerative colitis available today, which do you turn to first for patients hospitalized for acute severe ulcerative colitis? Let us know in our poll!
With many recently approved...
12/17/2024
Advances in Inflammatory Bowel Disease Network
Millie Long
Conference coverage
Millie Long, MD, on Defining Disease Severity in Ulcerative Colitis
12/16/2024
Dr Millie Long discusses the difference between the "snapshot" of disease activity and the "movie" of disease severity, and the importance of carefully assessing severity when choosing therapies and developing monitoring strategies for...
Dr Millie Long discusses the difference between the "snapshot" of disease activity and the "movie" of disease severity, and the importance of carefully assessing severity when choosing therapies and developing monitoring strategies for...
Dr Millie Long discusses the...
12/16/2024
Advances in Inflammatory Bowel Disease Network
Conference Coverage
Subcutaneous Mirikizumab Found Tolerable After Hypersensitivity Reaction to IV Infusion
12/10/2024
Jessica Garlewicz
A case study published in The American Journal of Gastroenterology presented at Advances in Inflammatory Bowel Diseases (AIBD), highlights a successful rechallenge with subcutaneous mirikizumab.
A case study published in The American Journal of Gastroenterology presented at Advances in Inflammatory Bowel Diseases (AIBD), highlights a successful rechallenge with subcutaneous mirikizumab.
A case study published in The...
12/10/2024
Advances in Inflammatory Bowel Disease Network
Video
Maria Abreu, MD, on When the First Advanced Therapy Fails in UC
12/09/2024
Maria Abreu, MD
What do you do when a first advanced therapy fails to control ulcerative colitis? Dr Abreu reviews her presentation from the Advances in IBD conference on how choose the next option among the many therapies available now.
What do you do when a first advanced therapy fails to control ulcerative colitis? Dr Abreu reviews her presentation from the Advances in IBD conference on how choose the next option among the many therapies available now.
What do you do when a first...
12/09/2024
Advances in Inflammatory Bowel Disease Network
Corey Siegel
Video
Corey Siegel, MD, on Shared Decision-Making in Ulcerative Colitis
12/06/2024
Dr Siegel, from Dartmouth-Hitchcock Medical Center in New Hampshire, reviews the importance of shared decision-making, careful listening, and providing guidance in developing treatment plans for patients with ulcerative colitis.
Dr Siegel, from Dartmouth-Hitchcock Medical Center in New Hampshire, reviews the importance of shared decision-making, careful listening, and providing guidance in developing treatment plans for patients with ulcerative colitis.
Dr Siegel, from...
12/06/2024
Advances in Inflammatory Bowel Disease Network
News
Real-World Results of First-Line Advanced Therapies for Ulcerative Proctitis
12/05/2024
Jessica Garlewicz
This retrospective cohort study, presented at the American College of Gastroenterology scientific meeting, examined the effectiveness of advanced therapies in bionaïve patients with ulcerative proctitis.
This retrospective cohort study, presented at the American College of Gastroenterology scientific meeting, examined the effectiveness of advanced therapies in bionaïve patients with ulcerative proctitis.
This retrospective cohort study,...
12/05/2024
Advances in Inflammatory Bowel Disease Network

News

News
Ozanimod Effective in Biologic-Exposed UC Patients
03/17/2025
Jessica Garlewicz
Some patients in the open-label extension of TRUE NORTH required more time to respond, but efficacy appears durable up to 3 years.
Some patients in the open-label extension of TRUE NORTH required more time to respond, but efficacy appears durable up to 3 years.
Some patients in the open-label...
03/17/2025
Advances in Inflammatory Bowel Disease Network
News
Upadacitinib Demonstrates Improved Outcomes Over Tofacitinib in Ulcerative Colitis
03/17/2025
Jessica Garlewicz
One year after initiation, patients receiving upadacitinib were at significantly lower risk of colectomy than those treated with tofacitinib.
One year after initiation, patients receiving upadacitinib were at significantly lower risk of colectomy than those treated with tofacitinib.
One year after initiation,...
03/17/2025
Advances in Inflammatory Bowel Disease Network
Research Highlights
Colectomy Associated With Risk of Kidney Failure
02/03/2025
Jessica Garlewicz
Patients undergoing colectomy may benefit from enhanced kidney function monitoring, surveillance, and timely referral to nephrology care.
Patients undergoing colectomy may benefit from enhanced kidney function monitoring, surveillance, and timely referral to nephrology care.
Patients undergoing colectomy...
02/03/2025
Advances in Inflammatory Bowel Disease Network
News
Real-World Results of First-Line Advanced Therapies for Ulcerative Proctitis
12/05/2024
Jessica Garlewicz
This retrospective cohort study, presented at the American College of Gastroenterology scientific meeting, examined the effectiveness of advanced therapies in bionaïve patients with ulcerative proctitis.
This retrospective cohort study, presented at the American College of Gastroenterology scientific meeting, examined the effectiveness of advanced therapies in bionaïve patients with ulcerative proctitis.
This retrospective cohort study,...
12/05/2024
Advances in Inflammatory Bowel Disease Network
News
Advanced Therapies for Patients With Severe Ulcerative Colitis
12/05/2024
Riya Gandhi, MA
A new study compares the efficacy of advanced therapies with corticosteroids in hospitalized patients with acute severe ulcerative colitis as first- and second-line therapies.
A new study compares the efficacy of advanced therapies with corticosteroids in hospitalized patients with acute severe ulcerative colitis as first- and second-line therapies.
A new study compares the...
12/05/2024
Advances in Inflammatory Bowel Disease Network
News
Intestinal Ultrasound Predicts Response to Therapy in Ulcerative Colitis
11/26/2024
Rebecca Mashaw
Intestinal ultrasound served as a surrogate for endoscopy in predicting drug-specific response within 6 weeks among patients with ulcerative colitis.
Intestinal ultrasound served as a surrogate for endoscopy in predicting drug-specific response within 6 weeks among patients with ulcerative colitis.
Intestinal ultrasound served as...
11/26/2024
Advances in Inflammatory Bowel Disease Network
News
Specific Factors Predict Rescue Therapy Response in Acute Severe Ulcerative Colitis
11/22/2024
Jolynn Tumolo
More than 3 dozen factors are associated with response to rescue therapy in patients with acute severe ulcerative colitis, according to a systematic review.
More than 3 dozen factors are associated with response to rescue therapy in patients with acute severe ulcerative colitis, according to a systematic review.
More than 3 dozen factors are...
11/22/2024
Advances in Inflammatory Bowel Disease Network
News
Impact of Concomitant Medications on Advanced Therapies for Ulcerative Colitis
11/12/2024
Most concomitant medications do not affect the efficacy or safety of advanced therapies in ulcerative colitis clinical trials, according to a recent study.
Most concomitant medications do not affect the efficacy or safety of advanced therapies in ulcerative colitis clinical trials, according to a recent study.
Most concomitant medications do...
11/12/2024
Advances in Inflammatory Bowel Disease Network
News
Standard Dosing of Infliximab Effective for Steroid-Refractory ASUC
10/18/2024
Jessica Garlewicz
While infliximab proved safe and effective for inducing remission in acute severe ulcerative colitis, higher doses and varied induction strategies showed no significant change in response.
While infliximab proved safe and effective for inducing remission in acute severe ulcerative colitis, higher doses and varied induction strategies showed no significant change in response.
While infliximab proved safe and...
10/18/2024
Advances in Inflammatory Bowel Disease Network
News
Scores Predict Corticosteroid Failure Risk in Patients With ASUC
10/03/2024
Jolynn Tumolo
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Risk of rescue scores that...
10/03/2024
Advances in Inflammatory Bowel Disease Network
News
NAFLD Linked to Worse Clinical Outcomes in Hospitalized Crohn’s Disease Patients
04/03/2025
Jessica Garlewicz
A new study examined 792,409 hospitalizations for Crohn's disease, of which 26,229 (3.3%) involved patients with coexisting nonalcoholic fatty liver disease.
A new study examined 792,409 hospitalizations for Crohn's disease, of which 26,229 (3.3%) involved patients with coexisting nonalcoholic fatty liver disease.
A new study examined 792,409...
04/03/2025
Gastroenterology
News
Early Response to Upadacitinib Predicts Long-Term Improvements in Crohn’s Disease
04/03/2025
Jessica Garlewicz
Patients with early response achieved higher rates of clinical remission and reductions in fatigue and impairment.
Patients with early response achieved higher rates of clinical remission and reductions in fatigue and impairment.
Patients with early response...
04/03/2025
Advances in Inflammatory Bowel Disease Network
FDA Alert
FDA Approves Both SC and IV Guselkumab for Crohn's Disease Among Adult Patients
03/24/2025
Rebecca Mashaw
This clearance follows last year's approval for ulcerative colitis and the first approval for subcutaneous and intravenous formulations to induce remission in adult patients with moderately to severely active Crohn's disease.
This clearance follows last year's approval for ulcerative colitis and the first approval for subcutaneous and intravenous formulations to induce remission in adult patients with moderately to severely active Crohn's disease.
This clearance follows last...
03/24/2025
Advances in Inflammatory Bowel Disease Network
News
Risankizumab Shows Efficacy in Treating Pouch Complications
03/19/2025
Rebecca Mashaw
Half of a small cohort of patients with Crohn’s disease of the pouch experienced clinical remission after 12 weeks of therapy with the IL-23 inhibitor.
Half of a small cohort of patients with Crohn’s disease of the pouch experienced clinical remission after 12 weeks of therapy with the IL-23 inhibitor.
Half of a small cohort of...
03/19/2025
Advances in Inflammatory Bowel Disease Network
News
Ozanimod Effective in Biologic-Exposed UC Patients
03/17/2025
Jessica Garlewicz
Some patients in the open-label extension of TRUE NORTH required more time to respond, but efficacy appears durable up to 3 years.
Some patients in the open-label extension of TRUE NORTH required more time to respond, but efficacy appears durable up to 3 years.
Some patients in the open-label...
03/17/2025
Advances in Inflammatory Bowel Disease Network
News
Upadacitinib Demonstrates Improved Outcomes Over Tofacitinib in Ulcerative Colitis
03/17/2025
Jessica Garlewicz
One year after initiation, patients receiving upadacitinib were at significantly lower risk of colectomy than those treated with tofacitinib.
One year after initiation, patients receiving upadacitinib were at significantly lower risk of colectomy than those treated with tofacitinib.
One year after initiation,...
03/17/2025
Advances in Inflammatory Bowel Disease Network
News
Global Incidence of Pediatric-Onset Inflammatory Bowel Disease Continues to Rise
03/14/2025
Jessica Garlewicz
Study findings highlight the importance of early diagnosis, improved treatment strategies, and equitable access to care for children affected by pediatric inflammatory bowel disease worldwide.
Study findings highlight the importance of early diagnosis, improved treatment strategies, and equitable access to care for children affected by pediatric inflammatory bowel disease worldwide.
Study findings highlight the...
03/14/2025
Advances in Inflammatory Bowel Disease Network
News
Challenges and Advances in the Management of Fistulizing Perianal Crohn’s Disease
03/13/2025
Jessica Garlewicz
Surgical interventions are often essential when biologics alone prove inadequate in the treatment of fistulizing perianal Crohn's disease.
Surgical interventions are often essential when biologics alone prove inadequate in the treatment of fistulizing perianal Crohn's disease.
Surgical interventions are often...
03/13/2025
Advances in Inflammatory Bowel Disease Network
News
Assessing Long-Term Outcomes of Crohn’s Disease Following Mucosal and Transmural Healing
03/13/2025
Rebecca Mashaw
Adopting standardized measures and use of less invasive assessment methods should enhance patient monitoring.
Adopting standardized measures and use of less invasive assessment methods should enhance patient monitoring.
Adopting standardized measures...
03/13/2025
Advances in Inflammatory Bowel Disease Network
News
Novel Therapies and Mucosal Healing in Crohn’s Disease
02/26/2025
Rebecca Mashaw
With mucosal healing now a primary goal of Crohn's disease (CD) treatment, investigators sought to compare the efficacy of novel therapies in achieving this goal in comparison to placebo.
With mucosal healing now a primary goal of Crohn's disease (CD) treatment, investigators sought to compare the efficacy of novel therapies in achieving this goal in comparison to placebo.
With mucosal healing now a...
02/26/2025
Advances in Inflammatory Bowel Disease Network

Insights

IBD Drive time logo
Podcast
IBD Drive Time: Frank Scott, MD, on the AGA Guidelines for Ulcerative Colitis Management
12/30/2024
In this IBD Drive Time podcast, Dr Frank Scott from the University of Colorado and host Dr Raymond Cross discuss updates in the AGA guidelines for ulcerative colitis.
In this IBD Drive Time podcast, Dr Frank Scott from the University of Colorado and host Dr Raymond Cross discuss updates in the AGA guidelines for ulcerative colitis.
In this IBD Drive Time podcast,...
12/30/2024
Advances in Inflammatory Bowel Disease Network
Maia Kayal
Video
Maia Kayal MD, on Strategies for Managing Patients When Mesalamine Fails
12/27/2024
Dr Kayal reviews the options available when patients with ulcerative colitis do not respond or lose response to mesalamine therapy, and the considerations of patient factors, patient preferences, and safety that should be taken into account.
Dr Kayal reviews the options available when patients with ulcerative colitis do not respond or lose response to mesalamine therapy, and the considerations of patient factors, patient preferences, and safety that should be taken into account.
Dr Kayal reviews the options...
12/27/2024
Advances in Inflammatory Bowel Disease Network
Video
Maria Abreu, MD, on When the First Advanced Therapy Fails in UC
12/09/2024
Maria Abreu, MD
What do you do when a first advanced therapy fails to control ulcerative colitis? Dr Abreu reviews her presentation from the Advances in IBD conference on how choose the next option among the many therapies available now.
What do you do when a first advanced therapy fails to control ulcerative colitis? Dr Abreu reviews her presentation from the Advances in IBD conference on how choose the next option among the many therapies available now.
What do you do when a first...
12/09/2024
Advances in Inflammatory Bowel Disease Network
Corey Siegel
Video
Corey Siegel, MD, on Shared Decision-Making in Ulcerative Colitis
12/06/2024
Dr Siegel, from Dartmouth-Hitchcock Medical Center in New Hampshire, reviews the importance of shared decision-making, careful listening, and providing guidance in developing treatment plans for patients with ulcerative colitis.
Dr Siegel, from Dartmouth-Hitchcock Medical Center in New Hampshire, reviews the importance of shared decision-making, careful listening, and providing guidance in developing treatment plans for patients with ulcerative colitis.
Dr Siegel, from...
12/06/2024
Advances in Inflammatory Bowel Disease Network
Millie Long
Video
Millie Long, MD, on Comparative Effectiveness in Ulcerative Colitis
10/21/2024
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation...
10/21/2024
Advances in Inflammatory Bowel Disease Network
David Rubin
Video
David Rubin, MD, on the QUASAR Maintenance Study of Guselkumab
10/15/2024
Dr Rubin discusses the results of the maintenance component of the QUASAR study of guselkumab, an IL-23/p19 inhibitor, in the treatment of ulcerative colitis, which he presented at Digestive Disease Week.
Dr Rubin discusses the results of the maintenance component of the QUASAR study of guselkumab, an IL-23/p19 inhibitor, in the treatment of ulcerative colitis, which he presented at Digestive Disease Week.
Dr Rubin discusses the results...
10/15/2024
Advances in Inflammatory Bowel Disease Network
Phillip Gu
Video
Phillip Gu, MD, on Acute Severe Ulcerative Colitis
09/07/2024
Dr Gu recaps his talk from the Los Angeles regional meeting on the most critical factors in caring for patients with acute severe ulcerative colitis, including testing for C difficile, involving the surgeon early, and ensuring patients...
Dr Gu recaps his talk from the Los Angeles regional meeting on the most critical factors in caring for patients with acute severe ulcerative colitis, including testing for C difficile, involving the surgeon early, and ensuring patients...
Dr Gu recaps his talk from the...
09/07/2024
Advances in Inflammatory Bowel Disease Network
Gil Y. Melmed, MD
Video
Gil Melmed, MD, on Comparative Effectiveness in Ulcerative Colitis
09/07/2024
Dr Melmed reviews his presentation from the AIBD regional meeting in Los Angeles on using dat
Dr Melmed reviews his presentation from the AIBD regional meeting in Los Angeles on using dat
Dr Melmed reviews his...
09/07/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Erin Forster, MD, on Risankizumab for Ulcerative Colitis
09/03/2024
Erin Forster, MD, MPH; Millie D. Long, MD, MPH; Raymond Cross, MD
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical...
09/03/2024
Advances in Inflammatory Bowel Disease Network
Ed Barnes
Video
Edward Barnes, MD, on Updates in Ulcerative Colitis
07/17/2024
Dr Barnes provides updates on advances in the treatment of ulcerative colitis, including new therapies approved and how those therapies could change clinical practice.
Dr Barnes provides updates on advances in the treatment of ulcerative colitis, including new therapies approved and how those therapies could change clinical practice.
Dr Barnes provides updates on...
07/17/2024
Advances in Inflammatory Bowel Disease Network
Sara Horst
Video
Sara Horst, MD, on Telemedicine for IBD Care
03/19/2025
Sara Horst, MD
Dr Horst reviews how the use of telemedicine has become a game-changer in enabling access to care for patients with inflammatory bowel disease, especially since the COVID pandemic.
Dr Horst reviews how the use of telemedicine has become a game-changer in enabling access to care for patients with inflammatory bowel disease, especially since the COVID pandemic.
Dr Horst reviews how the use of...
03/19/2025
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Freddy Caldera, DO, on Disease Prevention in IBD
03/17/2025
Millie D. Long, MD, MPH; Freddy Caldera, DO
Freddy Caldera, DO, PhD, and IBD Drive Time cohost Millie Long, MD, discuss the new AGA best practice advice on preventing diseases and monitoring for complications in patients with inflammatory bowel disease.
Freddy Caldera, DO, PhD, and IBD Drive Time cohost Millie Long, MD, discuss the new AGA best practice advice on preventing diseases and monitoring for complications in patients with inflammatory bowel disease.
Freddy Caldera, DO, PhD, and IBD...
03/17/2025
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Detecting and Managing Anorectal Cancer
03/04/2025
Raymond Cross, MD; Millie D. Long, MD, MPH; Jessica Korman
Andrea Bafford, MD, and Jessica Korman, MD, join Drs Raymond Cross and Millie Long to review the challenges of detecting, diagnosing, and managing anorectal cancer among patients with inflammatory bowel disease.
Andrea Bafford, MD, and Jessica Korman, MD, join Drs Raymond Cross and Millie Long to review the challenges of detecting, diagnosing, and managing anorectal cancer among patients with inflammatory bowel disease.
Andrea Bafford, MD, and Jessica...
03/04/2025
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcasts
IBD Drive Time: Jami Kinnucan, MD, on Using Cannabis in IBD
02/12/2025
Jami Kinnucan; Raymond Cross, MD; Millie D. Long, MD, MPH
Jami Kinnucan, MD, reviews the facts and fallacies about the use of cannabis for the treatment of inflammatory bowel disease, and how to discuss the issue with patients, with IBD Drive Time hosts Raymond Cross, MD, and Millie Long, MD.
Jami Kinnucan, MD, reviews the facts and fallacies about the use of cannabis for the treatment of inflammatory bowel disease, and how to discuss the issue with patients, with IBD Drive Time hosts Raymond Cross, MD, and Millie Long, MD.
Jami Kinnucan, MD, reviews the...
02/12/2025
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Lin Chang, MD, on IBS in IBD
01/27/2025
Raymond Cross, MD
Dr Lin Chang joins hosts Raymond Cross, MD, and Millie Long, MD, to discuss how patient with inflammatory bowel disease may also have underlying irritable bowel syndrome, how to diagnose the condition, and the best options for treatment.
Dr Lin Chang joins hosts Raymond Cross, MD, and Millie Long, MD, to discuss how patient with inflammatory bowel disease may also have underlying irritable bowel syndrome, how to diagnose the condition, and the best options for treatment.
Dr Lin Chang joins hosts Raymond...
01/27/2025
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Sara Horst, MD, on the Best of ACG
01/20/2025
Raymond Cross, MD
Drs Ray Cross and Millie Long discuss with guest Dr Sara Horst the best presentations and abstracts on inflammatory bowel disease from the American College of Gastroenterology scientific meeting held in October.
Drs Ray Cross and Millie Long discuss with guest Dr Sara Horst the best presentations and abstracts on inflammatory bowel disease from the American College of Gastroenterology scientific meeting held in October.
Drs Ray Cross and Millie Long...
01/20/2025
Advances in Inflammatory Bowel Disease Network
Marla Dubinsky
Conference coverage
Marla Dubinsky, MD, on Risk Stratification in Crohn's Disease
01/16/2025
Dr Dubinsky opened the 2024 Advances in Inflammatory Bowel Disease conference with a firm statement that virtually all patients with Crohn's disease should be treated quickly after diagnosis with approved and effective therapies to help...
Dr Dubinsky opened the 2024 Advances in Inflammatory Bowel Disease conference with a firm statement that virtually all patients with Crohn's disease should be treated quickly after diagnosis with approved and effective therapies to help...
Dr Dubinsky opened the 2024...
01/16/2025
Advances in Inflammatory Bowel Disease Network
Ed Loftus
Video
Edward Loftus, MD, on Upper GI Crohn's Disease
01/07/2025
Edward V. Loftus, Jr., MD
Dr Loftus explains how Crohn's disease can affect the upper gastrointestinal system, from the mouth to the duodenum, and the options for treating this rare presentation.
Dr Loftus explains how Crohn's disease can affect the upper gastrointestinal system, from the mouth to the duodenum, and the options for treating this rare presentation.
Dr Loftus explains how Crohn's...
01/07/2025
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Frank Scott, MD, on the AGA Guidelines for Ulcerative Colitis Management
12/30/2024
In this IBD Drive Time podcast, Dr Frank Scott from the University of Colorado and host Dr Raymond Cross discuss updates in the AGA guidelines for ulcerative colitis.
In this IBD Drive Time podcast, Dr Frank Scott from the University of Colorado and host Dr Raymond Cross discuss updates in the AGA guidelines for ulcerative colitis.
In this IBD Drive Time podcast,...
12/30/2024
Advances in Inflammatory Bowel Disease Network
Maia Kayal
Video
Maia Kayal MD, on Strategies for Managing Patients When Mesalamine Fails
12/27/2024
Dr Kayal reviews the options available when patients with ulcerative colitis do not respond or lose response to mesalamine therapy, and the considerations of patient factors, patient preferences, and safety that should be taken into account.
Dr Kayal reviews the options available when patients with ulcerative colitis do not respond or lose response to mesalamine therapy, and the considerations of patient factors, patient preferences, and safety that should be taken into account.
Dr Kayal reviews the options...
12/27/2024
Advances in Inflammatory Bowel Disease Network

Interactive Features

medical quiz
Quiz
Surgical Outcomes for Crohn's Disease vs Ulcerative Colitis
07/14/2023
Priyam Vora
Are surgical outcomes the same for patients with Crohn's disease as they are for patients with ulcerative colitis? Find out with a quick quiz.
Are surgical outcomes the same for patients with Crohn's disease as they are for patients with ulcerative colitis? Find out with a quick quiz.
Are surgical outcomes the same...
07/14/2023
Advances in Inflammatory Bowel Disease Network
OR shot
Quiz
Colectomy Rates Among Patients With UC
02/22/2023
Recent research looked at rates of colectomy among patients with ulcerative colitis to determine if there were significant differences by race or ethnicity. See if you can guess what that study revealed by taking our quick quiz.
Recent research looked at rates of colectomy among patients with ulcerative colitis to determine if there were significant differences by race or ethnicity. See if you can guess what that study revealed by taking our quick quiz.
Recent research looked at rates...
02/22/2023
Advances in Inflammatory Bowel Disease Network
Quiz
Upper GI Crohn's Disease
03/18/2025
Rebecca Mashaw
How much do you know about upper GI Crohn's disease? Take our quiz to check your knowledge!
How much do you know about upper GI Crohn's disease? Take our quiz to check your knowledge!
How much do you know about upper...
03/18/2025
Advances in Inflammatory Bowel Disease Network
Quiz
Preoperative Nutrition for Crohn’s Disease Patients
03/18/2025
Rebecca Mashaw
What is one benefit of preoperative exclusive enteral nutrition for Crohn’s disease patients? Take our quiz to find out if you know the answer!
What is one benefit of preoperative exclusive enteral nutrition for Crohn’s disease patients? Take our quiz to find out if you know the answer!
What is one benefit of...
03/18/2025
Advances in Inflammatory Bowel Disease Network
Quiz
Risk Factors for Surgery in Crohn’s Disease
02/26/2025
Rebecca Mashaw
Estimates vary but indicate that half or more of patients with Crohn's disease will require surgery at some point in their disease course. Do you know which factors place your patients at high risk for surgery? Take our quiz to find out!
Estimates vary but indicate that half or more of patients with Crohn's disease will require surgery at some point in their disease course. Do you know which factors place your patients at high risk for surgery? Take our quiz to find out!
Estimates vary but indicate that...
02/26/2025
Advances in Inflammatory Bowel Disease Network
quiz
Quiz
Does Crohn's Disease or Ulcerative Colitis Present the Highest Risk of Multiple EIMs?
12/11/2023
Priyam Vora
Extraintestinal manifestations (EIMs) are seen in 25-40% of patients with inflammatory bowel disease. Take a quick quiz to find out who is more at risk of developing multiple EIMs.
Extraintestinal manifestations (EIMs) are seen in 25-40% of patients with inflammatory bowel disease. Take a quick quiz to find out who is more at risk of developing multiple EIMs.
Extraintestinal manifestations...
12/11/2023
Advances in Inflammatory Bowel Disease Network
light bulb+quiz
Quiz
Positioning Diet for Crohn's Disease
09/04/2023
Priyam Vora
David Rubin, MD, explained some key differences between the different diets in the management of Crohn's disease to achieve the best possible outcomes. Do you know what diet is the most palatable and sustainable? Take our quiz to find out!
David Rubin, MD, explained some key differences between the different diets in the management of Crohn's disease to achieve the best possible outcomes. Do you know what diet is the most palatable and sustainable? Take our quiz to find out!
David Rubin, MD, explained some...
09/04/2023
Advances in Inflammatory Bowel Disease Network
quiz
Quiz
The 3 Pillars of IBD Care
07/18/2023
Priyam Vora
Do you know the essential principles of management of inflammatory bowel disease? Take a quick quiz to find out!
Do you know the essential principles of management of inflammatory bowel disease? Take a quick quiz to find out!
Do you know the essential...
07/18/2023
Advances in Inflammatory Bowel Disease Network
medical quiz
Quiz
Surgical Outcomes for Crohn's Disease vs Ulcerative Colitis
07/14/2023
Priyam Vora
Are surgical outcomes the same for patients with Crohn's disease as they are for patients with ulcerative colitis? Find out with a quick quiz.
Are surgical outcomes the same for patients with Crohn's disease as they are for patients with ulcerative colitis? Find out with a quick quiz.
Are surgical outcomes the same...
07/14/2023
Advances in Inflammatory Bowel Disease Network
Quiz
Role of Biologic Agents in IBD
06/14/2023
Priyam Vora
Are biologic agents the ultimate answer in the treatment of intestinal inflammation? Test your knowledge here!
Are biologic agents the ultimate answer in the treatment of intestinal inflammation? Test your knowledge here!
Are biologic agents the ultimate...
06/14/2023
Advances in Inflammatory Bowel Disease Network
coffee+quiz
Quiz
Resection or Medical Therapy for Early Ileocecal Crohn Disease?
05/24/2023
Experts explored the possibility of resection for patients with Crohn disease in the early stages. What did they conclude? Take our quiz to test your knowledge!
Experts explored the possibility of resection for patients with Crohn disease in the early stages. What did they conclude? Take our quiz to test your knowledge!
Experts explored the possibility...
05/24/2023
Advances in Inflammatory Bowel Disease Network
doc writing notes
Quiz
SIBO and Crohn's Disease
04/28/2023
Rebecca Mashaw
Is there any link between small intestinal bacterial overgrowth and clinical relapse in patients with quiescent Crohn disease? Take the test to find out!
Is there any link between small intestinal bacterial overgrowth and clinical relapse in patients with quiescent Crohn disease? Take the test to find out!
Is there any link between small...
04/28/2023
Advances in Inflammatory Bowel Disease Network

Latest News

News
Ozanimod Effective in Biologic-Exposed UC Patients
03/17/2025
Jessica Garlewicz
Some patients in the open-label extension of TRUE NORTH required more time to respond, but efficacy appears durable up to 3 years.
Some patients in the open-label extension of TRUE NORTH required more time to respond, but efficacy appears durable up to 3 years.
Some patients in the open-label...
03/17/2025
Advances in Inflammatory Bowel Disease Network
News
Upadacitinib Demonstrates Improved Outcomes Over Tofacitinib in Ulcerative Colitis
03/17/2025
Jessica Garlewicz
One year after initiation, patients receiving upadacitinib were at significantly lower risk of colectomy than those treated with tofacitinib.
One year after initiation, patients receiving upadacitinib were at significantly lower risk of colectomy than those treated with tofacitinib.
One year after initiation,...
03/17/2025
Advances in Inflammatory Bowel Disease Network
Research Highlights
Colectomy Associated With Risk of Kidney Failure
02/03/2025
Jessica Garlewicz
Patients undergoing colectomy may benefit from enhanced kidney function monitoring, surveillance, and timely referral to nephrology care.
Patients undergoing colectomy may benefit from enhanced kidney function monitoring, surveillance, and timely referral to nephrology care.
Patients undergoing colectomy...
02/03/2025
Advances in Inflammatory Bowel Disease Network
News
Real-World Results of First-Line Advanced Therapies for Ulcerative Proctitis
12/05/2024
Jessica Garlewicz
This retrospective cohort study, presented at the American College of Gastroenterology scientific meeting, examined the effectiveness of advanced therapies in bionaïve patients with ulcerative proctitis.
This retrospective cohort study, presented at the American College of Gastroenterology scientific meeting, examined the effectiveness of advanced therapies in bionaïve patients with ulcerative proctitis.
This retrospective cohort study,...
12/05/2024
Advances in Inflammatory Bowel Disease Network
News
Advanced Therapies for Patients With Severe Ulcerative Colitis
12/05/2024
Riya Gandhi, MA
A new study compares the efficacy of advanced therapies with corticosteroids in hospitalized patients with acute severe ulcerative colitis as first- and second-line therapies.
A new study compares the efficacy of advanced therapies with corticosteroids in hospitalized patients with acute severe ulcerative colitis as first- and second-line therapies.
A new study compares the...
12/05/2024
Advances in Inflammatory Bowel Disease Network
News
Intestinal Ultrasound Predicts Response to Therapy in Ulcerative Colitis
11/26/2024
Rebecca Mashaw
Intestinal ultrasound served as a surrogate for endoscopy in predicting drug-specific response within 6 weeks among patients with ulcerative colitis.
Intestinal ultrasound served as a surrogate for endoscopy in predicting drug-specific response within 6 weeks among patients with ulcerative colitis.
Intestinal ultrasound served as...
11/26/2024
Advances in Inflammatory Bowel Disease Network
News
Specific Factors Predict Rescue Therapy Response in Acute Severe Ulcerative Colitis
11/22/2024
Jolynn Tumolo
More than 3 dozen factors are associated with response to rescue therapy in patients with acute severe ulcerative colitis, according to a systematic review.
More than 3 dozen factors are associated with response to rescue therapy in patients with acute severe ulcerative colitis, according to a systematic review.
More than 3 dozen factors are...
11/22/2024
Advances in Inflammatory Bowel Disease Network
News
Impact of Concomitant Medications on Advanced Therapies for Ulcerative Colitis
11/12/2024
Most concomitant medications do not affect the efficacy or safety of advanced therapies in ulcerative colitis clinical trials, according to a recent study.
Most concomitant medications do not affect the efficacy or safety of advanced therapies in ulcerative colitis clinical trials, according to a recent study.
Most concomitant medications do...
11/12/2024
Advances in Inflammatory Bowel Disease Network
News
Standard Dosing of Infliximab Effective for Steroid-Refractory ASUC
10/18/2024
Jessica Garlewicz
While infliximab proved safe and effective for inducing remission in acute severe ulcerative colitis, higher doses and varied induction strategies showed no significant change in response.
While infliximab proved safe and effective for inducing remission in acute severe ulcerative colitis, higher doses and varied induction strategies showed no significant change in response.
While infliximab proved safe and...
10/18/2024
Advances in Inflammatory Bowel Disease Network
News
Scores Predict Corticosteroid Failure Risk in Patients With ASUC
10/03/2024
Jolynn Tumolo
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Risk of rescue scores that...
10/03/2024
Advances in Inflammatory Bowel Disease Network
News
NAFLD Linked to Worse Clinical Outcomes in Hospitalized Crohn’s Disease Patients
04/03/2025
Jessica Garlewicz
A new study examined 792,409 hospitalizations for Crohn's disease, of which 26,229 (3.3%) involved patients with coexisting nonalcoholic fatty liver disease.
A new study examined 792,409 hospitalizations for Crohn's disease, of which 26,229 (3.3%) involved patients with coexisting nonalcoholic fatty liver disease.
A new study examined 792,409...
04/03/2025
Gastroenterology
News
Early Response to Upadacitinib Predicts Long-Term Improvements in Crohn’s Disease
04/03/2025
Jessica Garlewicz
Patients with early response achieved higher rates of clinical remission and reductions in fatigue and impairment.
Patients with early response achieved higher rates of clinical remission and reductions in fatigue and impairment.
Patients with early response...
04/03/2025
Advances in Inflammatory Bowel Disease Network
FDA Alert
FDA Approves Both SC and IV Guselkumab for Crohn's Disease Among Adult Patients
03/24/2025
Rebecca Mashaw
This clearance follows last year's approval for ulcerative colitis and the first approval for subcutaneous and intravenous formulations to induce remission in adult patients with moderately to severely active Crohn's disease.
This clearance follows last year's approval for ulcerative colitis and the first approval for subcutaneous and intravenous formulations to induce remission in adult patients with moderately to severely active Crohn's disease.
This clearance follows last...
03/24/2025
Advances in Inflammatory Bowel Disease Network
News
Risankizumab Shows Efficacy in Treating Pouch Complications
03/19/2025
Rebecca Mashaw
Half of a small cohort of patients with Crohn’s disease of the pouch experienced clinical remission after 12 weeks of therapy with the IL-23 inhibitor.
Half of a small cohort of patients with Crohn’s disease of the pouch experienced clinical remission after 12 weeks of therapy with the IL-23 inhibitor.
Half of a small cohort of...
03/19/2025
Advances in Inflammatory Bowel Disease Network
News
Ozanimod Effective in Biologic-Exposed UC Patients
03/17/2025
Jessica Garlewicz
Some patients in the open-label extension of TRUE NORTH required more time to respond, but efficacy appears durable up to 3 years.
Some patients in the open-label extension of TRUE NORTH required more time to respond, but efficacy appears durable up to 3 years.
Some patients in the open-label...
03/17/2025
Advances in Inflammatory Bowel Disease Network
News
Upadacitinib Demonstrates Improved Outcomes Over Tofacitinib in Ulcerative Colitis
03/17/2025
Jessica Garlewicz
One year after initiation, patients receiving upadacitinib were at significantly lower risk of colectomy than those treated with tofacitinib.
One year after initiation, patients receiving upadacitinib were at significantly lower risk of colectomy than those treated with tofacitinib.
One year after initiation,...
03/17/2025
Advances in Inflammatory Bowel Disease Network
News
Global Incidence of Pediatric-Onset Inflammatory Bowel Disease Continues to Rise
03/14/2025
Jessica Garlewicz
Study findings highlight the importance of early diagnosis, improved treatment strategies, and equitable access to care for children affected by pediatric inflammatory bowel disease worldwide.
Study findings highlight the importance of early diagnosis, improved treatment strategies, and equitable access to care for children affected by pediatric inflammatory bowel disease worldwide.
Study findings highlight the...
03/14/2025
Advances in Inflammatory Bowel Disease Network
News
Challenges and Advances in the Management of Fistulizing Perianal Crohn’s Disease
03/13/2025
Jessica Garlewicz
Surgical interventions are often essential when biologics alone prove inadequate in the treatment of fistulizing perianal Crohn's disease.
Surgical interventions are often essential when biologics alone prove inadequate in the treatment of fistulizing perianal Crohn's disease.
Surgical interventions are often...
03/13/2025
Advances in Inflammatory Bowel Disease Network
News
Assessing Long-Term Outcomes of Crohn’s Disease Following Mucosal and Transmural Healing
03/13/2025
Rebecca Mashaw
Adopting standardized measures and use of less invasive assessment methods should enhance patient monitoring.
Adopting standardized measures and use of less invasive assessment methods should enhance patient monitoring.
Adopting standardized measures...
03/13/2025
Advances in Inflammatory Bowel Disease Network
News
Novel Therapies and Mucosal Healing in Crohn’s Disease
02/26/2025
Rebecca Mashaw
With mucosal healing now a primary goal of Crohn's disease (CD) treatment, investigators sought to compare the efficacy of novel therapies in achieving this goal in comparison to placebo.
With mucosal healing now a primary goal of Crohn's disease (CD) treatment, investigators sought to compare the efficacy of novel therapies in achieving this goal in comparison to placebo.
With mucosal healing now a...
02/26/2025
Advances in Inflammatory Bowel Disease Network

Latest Podcasts

IBD Drive time logo
Podcast
IBD Drive Time: Frank Scott, MD, on the AGA Guidelines for Ulcerative Colitis Management
12/30/2024
In this IBD Drive Time podcast, Dr Frank Scott from the University of Colorado and host Dr Raymond Cross discuss updates in the AGA guidelines for ulcerative colitis.
In this IBD Drive Time podcast, Dr Frank Scott from the University of Colorado and host Dr Raymond Cross discuss updates in the AGA guidelines for ulcerative colitis.
In this IBD Drive Time podcast,...
12/30/2024
Advances in Inflammatory Bowel Disease Network
Millie Long
Video
Millie Long, MD, on Comparative Effectiveness in Ulcerative Colitis
10/21/2024
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation...
10/21/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Erin Forster, MD, on Risankizumab for Ulcerative Colitis
09/03/2024
Erin Forster, MD, MPH; Millie D. Long, MD, MPH; Raymond Cross, MD
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical...
09/03/2024
Advances in Inflammatory Bowel Disease Network
David Hudesman
Podcast
David Hudesman, MD, on Efficacy of Tofacitinib Induction for Ulcerative Colitis
03/07/2023
Dr Hudesman reviews the findings of a post hoc analysis he and colleagues conducted to assess associations between C-reactive protein, partial Mayo score, and efficacy outcomes during tofacitinib induction.
Dr Hudesman reviews the findings of a post hoc analysis he and colleagues conducted to assess associations between C-reactive protein, partial Mayo score, and efficacy outcomes during tofacitinib induction.
Dr Hudesman reviews the findings...
03/07/2023
Advances in Inflammatory Bowel Disease Network
Bruce Sands
Podcast
Bruce Sands, MD, on the VEGA Study of Combination Biologic Therapy in UC
12/19/2022
Dr Sands provides an overview of the VEGA study, the first of its kind to combine 2 biologic agents to attempt to achieve higher rates of remission among patients with ulcerative colitis.
Dr Sands provides an overview of the VEGA study, the first of its kind to combine 2 biologic agents to attempt to achieve higher rates of remission among patients with ulcerative colitis.
Dr Sands provides an overview of...
12/19/2022
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Freddy Caldera, DO, on Disease Prevention in IBD
03/17/2025
Millie D. Long, MD, MPH; Freddy Caldera, DO
Freddy Caldera, DO, PhD, and IBD Drive Time cohost Millie Long, MD, discuss the new AGA best practice advice on preventing diseases and monitoring for complications in patients with inflammatory bowel disease.
Freddy Caldera, DO, PhD, and IBD Drive Time cohost Millie Long, MD, discuss the new AGA best practice advice on preventing diseases and monitoring for complications in patients with inflammatory bowel disease.
Freddy Caldera, DO, PhD, and IBD...
03/17/2025
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Detecting and Managing Anorectal Cancer
03/04/2025
Raymond Cross, MD; Millie D. Long, MD, MPH; Jessica Korman
Andrea Bafford, MD, and Jessica Korman, MD, join Drs Raymond Cross and Millie Long to review the challenges of detecting, diagnosing, and managing anorectal cancer among patients with inflammatory bowel disease.
Andrea Bafford, MD, and Jessica Korman, MD, join Drs Raymond Cross and Millie Long to review the challenges of detecting, diagnosing, and managing anorectal cancer among patients with inflammatory bowel disease.
Andrea Bafford, MD, and Jessica...
03/04/2025
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcasts
IBD Drive Time: Jami Kinnucan, MD, on Using Cannabis in IBD
02/12/2025
Jami Kinnucan; Raymond Cross, MD; Millie D. Long, MD, MPH
Jami Kinnucan, MD, reviews the facts and fallacies about the use of cannabis for the treatment of inflammatory bowel disease, and how to discuss the issue with patients, with IBD Drive Time hosts Raymond Cross, MD, and Millie Long, MD.
Jami Kinnucan, MD, reviews the facts and fallacies about the use of cannabis for the treatment of inflammatory bowel disease, and how to discuss the issue with patients, with IBD Drive Time hosts Raymond Cross, MD, and Millie Long, MD.
Jami Kinnucan, MD, reviews the...
02/12/2025
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Lin Chang, MD, on IBS in IBD
01/27/2025
Raymond Cross, MD
Dr Lin Chang joins hosts Raymond Cross, MD, and Millie Long, MD, to discuss how patient with inflammatory bowel disease may also have underlying irritable bowel syndrome, how to diagnose the condition, and the best options for treatment.
Dr Lin Chang joins hosts Raymond Cross, MD, and Millie Long, MD, to discuss how patient with inflammatory bowel disease may also have underlying irritable bowel syndrome, how to diagnose the condition, and the best options for treatment.
Dr Lin Chang joins hosts Raymond...
01/27/2025
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Sara Horst, MD, on the Best of ACG
01/20/2025
Raymond Cross, MD
Drs Ray Cross and Millie Long discuss with guest Dr Sara Horst the best presentations and abstracts on inflammatory bowel disease from the American College of Gastroenterology scientific meeting held in October.
Drs Ray Cross and Millie Long discuss with guest Dr Sara Horst the best presentations and abstracts on inflammatory bowel disease from the American College of Gastroenterology scientific meeting held in October.
Drs Ray Cross and Millie Long...
01/20/2025
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Frank Scott, MD, on the AGA Guidelines for Ulcerative Colitis Management
12/30/2024
In this IBD Drive Time podcast, Dr Frank Scott from the University of Colorado and host Dr Raymond Cross discuss updates in the AGA guidelines for ulcerative colitis.
In this IBD Drive Time podcast, Dr Frank Scott from the University of Colorado and host Dr Raymond Cross discuss updates in the AGA guidelines for ulcerative colitis.
In this IBD Drive Time podcast,...
12/30/2024
Advances in Inflammatory Bowel Disease Network
Millie Long
Video
Millie Long, MD, on Comparative Effectiveness in Ulcerative Colitis
10/21/2024
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation...
10/21/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Drs James Lewis and Laura Raffals on SPARC
10/21/2024
Dr Raymond Cross hosts Drs James Lewis and Laura Raffals in a discussion of SPARC, a study of adults with inflammatory bowel disease in which patients are followed prospectively to collect data about to allow prediction of disease course and...
Dr Raymond Cross hosts Drs James Lewis and Laura Raffals in a discussion of SPARC, a study of adults with inflammatory bowel disease in which patients are followed prospectively to collect data about to allow prediction of disease course and...
Dr Raymond Cross hosts Drs James...
10/21/2024
Advances in Inflammatory Bowel Disease Network
Freddy Caldera
Podcast
Freddy Caldera, DO, on the RSV Vaccine for Patients With IBD
10/11/2024
Freddy Caldera
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University...
10/11/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Updates on the PIANO Study of IBD and Pregnancy
10/07/2024
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study. 
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study. 
IBD Drive Time Hosts Millie...
10/07/2024
Advances in Inflammatory Bowel Disease Network

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use